Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a new revision entry for v3.3.2 and removed v3.3.1 from the history. This updates the release version shown but does not affect study data or user-facing content.
    Difference
    0.1%
    Check dated 2025-12-01T10:58:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:39:03.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and NIH operating status that previously appeared on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:22:07.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new version dated 2025-02-03 was added to the Record History, including updates to multiple sections such as Participant Flow, Baseline Characteristics, Outcome Measures, and Adverse Events.
    Difference
    0.2%
    Check dated 2025-11-03T01:04:33.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    10%
    Check dated 2025-10-05T10:00:09.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Released a new version tag (v3.1.0) replacing the old one (v3.0.2); core content and features are not shown to be affected.
    Difference
    0.3%
    Check dated 2025-09-28T03:13:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.